[Correlation between clinical aggressiveness of thymic epithelial tumors and expression of tumor suppressor gene products (p53, p27)]

Fukuoka Igaku Zasshi. 1999 Aug;90(8):339-41.
[Article in Japanese]

Abstract

It is impossible to predict malignant potential of thymomas by conventional histopathological examination. In order to find a malignant marker of thymoma, we immunohistochemically examined the expression of the products of p53 and p27kip1, potential tumor suppressor genes in thymic epithelial tumors. The thymic epithelial tumors examined in the present study included 13 non-invasive thymomas, 7 invasive thymomas, and 4 thymic carcinomas. The thymic epithelial cells showed abnormal accumulation of p53 protein in 2 of 13 non-invasive thymomas (15.4%), 4 of 7 invasive thymomas (50%), and 3 of 4 thymic carcinomas (75%). The frequency of p53-expression paralleled with clinical aggressiveness. On the other hand, p27 showed no correlation with clinical aggressiveness. In conclusion, the present results suggest that the presence of p53-positive epithelial cells might be a useful indicator to predict malignant potential of thymoma.

Publication types

  • English Abstract

MeSH terms

  • Cell Cycle Proteins*
  • Cyclin-Dependent Kinase Inhibitor p27
  • Cyclin-Dependent Kinases / antagonists & inhibitors
  • Genes, Tumor Suppressor
  • Humans
  • Immunohistochemistry
  • Microtubule-Associated Proteins / analysis
  • Thymoma / genetics
  • Thymoma / pathology*
  • Thymus Neoplasms / genetics
  • Thymus Neoplasms / pathology*
  • Tumor Suppressor Protein p53 / analysis*
  • Tumor Suppressor Proteins*

Substances

  • Cell Cycle Proteins
  • Microtubule-Associated Proteins
  • Tumor Suppressor Protein p53
  • Tumor Suppressor Proteins
  • Cyclin-Dependent Kinase Inhibitor p27
  • Cyclin-Dependent Kinases